- Corporate Officers - D
- Duliege Anne-marie
Insider Trading History of Duliege Anne-marie
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Duliege Anne-marie since 2008.
The trader's CIK number is 1419579.
At the time of the last reporting, Duliege Anne-marie was the Chief Medical Office of Rigel Pharmaceuticals Inc. (stock ticker symbol RIGL).
Also see all insider trading activities at Rigel Pharmaceuticals Inc.
Note that in the past
Duliege Anne-Marie also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Rigel Pharmaceuticals Inc (RIGL) by Duliege Anne-marie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | RIGL | 0 | $0 | 179,500 | $627,845 | 169,500 | $397,635 |
| 2017 | RIGL | 0 | $0 | 10,000 | $25,455 | 0 | $0 |
Yearly summary of insider trading at Affymax Inc (AFFY) by Duliege Anne-marie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | AFFY | 0 | $0 | 37,676 | $773,669 | 23,227 | $140,755 |
| 2011 | AFFY | 0 | $0 | 10,142 | $55,332 | 0 | $0 |
| 2010 | AFFY | 0 | $0 | 28,280 | $604,030 | 26,583 | $104,368 |
| 2009 | AFFY | 0 | $0 | 37,947 | $883,649 | 36,250 | $29,000 |
| 2008 | AFFY | 0 | $0 | 1,038 | $16,089 | 0 | $0 |
Yearly summary of insider trading at Chemocentryx, Inc. (CCXI) by Duliege Anne-marie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CCXI | 0 | $0 | 4,970 | $23,433 | 0 | $0 |
Insider trading activities at 3 companies by Duliege Anne-marie:
1. Rigel Pharmaceuticals Inc (RIGL)
2. Affymax Inc (AFFY)
3. Chemocentryx, Inc. (CCXI)
Table 1. Insider trading of Rigel Pharmaceuticals Inc (RIGL) by Duliege Anne-marie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-09-17 | RIGL | Option Ex | 153,000 | 2.33 | 355,725 |
| 2018-09-17 | RIGL | Sale | 153,000 | 3.50 | 535,500 |
| 2018-09-04 | RIGL | Option Ex | 16,500 | 2.54 | 41,910 |
| 2018-09-04 | RIGL | Sale | 16,500 | 3.51 | 57,865 |
| 2018-07-02 | RIGL | Sale | 5,000 | 2.79 | 13,930 |
| 2018-04-20 | RIGL | Sale | 5,000 | 4.11 | 20,550 |
| 2017-07-05 | RIGL | Sale | 5,000 | 2.69 | 13,425 |
| 2017-01-03 | RIGL | Sale | 5,000 | 2.41 | 12,030 |
Table 2. Insider trading of Affymax Inc (AFFY) by Duliege Anne-marie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-11-01 | AFFY | Sale | 1,056 | 22.90 | 24,182 |
| 2012-10-10 | AFFY | Sale | 9,704 | 24.00 | 232,896 |
| 2012-09-13 | AFFY | Option Ex | 23,227 | 6.06 | 140,755 |
| 2012-09-13 | AFFY | Sale | 23,227 | 20.00 | 464,540 |
| 2012-05-25 | AFFY | Sale | 3,689 | 14.11 | 52,051 |
| 2011-11-01 | AFFY | Sale | 823 | 5.17 | 4,254 |
| 2011-08-17 | AFFY | Sale | 5,296 | 4.73 | 25,050 |
| 2011-06-23 | AFFY | Sale | 4,023 | 6.47 | 26,028 |
| 2010-05-04 | AFFY | Option Ex | 2,500 | 4.36 | 10,900 |
| 2010-05-04 | AFFY | Sale | 4,197 | 24.07 | 101,021 |
| 2010-03-15 | AFFY | Option Ex | 21,583 | 4.24 | 91,468 |
| 2010-03-16 | AFFY | Option Ex | 2,500 | .80 | 2,000 |
| 2010-03-15 | AFFY | Sale | 21,583 | 20.88 | 450,609 |
| 2010-03-16 | AFFY | Sale | 2,500 | 20.96 | 52,400 |
| 2009-11-10 | AFFY | Sale | 3,000 | 20.27 | 60,810 |
| 2009-11-10 | AFFY | Option Ex | 3,000 | .80 | 2,400 |
| 2009-09-03 | AFFY | Option Ex | 3,250 | .80 | 2,600 |
| 2009-09-03 | AFFY | Sale | 3,250 | 22.00 | 71,500 |
| 2009-09-01 | AFFY | Option Ex | 30,000 | .80 | 24,000 |
| 2009-09-01 | AFFY | Sale | 30,000 | 24.06 | 721,710 |
| 2009-05-01 | AFFY | Sale | 1,697 | 17.46 | 29,629 |
| 2008-05-15 | AFFY | Sale | 1,038 | 15.50 | 16,089 |
Table 3. Insider trading of Chemocentryx, Inc. (CCXI) by Duliege Anne-marie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-11-18 | CCXI | Sale | 4,970 | 4.71 | 23,433 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Duliege Anne-marie
(Chief Medical Office of Rigel Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.